https://regulatorypathfinder.com/fda-slowdown/2025-09-24T09:56:45+00:00https://regulatorypathfinder.com/post-1-why-regulatory-strategy-can-make-or-break-your-digital-health-startup/2025-10-08T11:00:30+00:00https://regulatorypathfinder.com/post-2-medical-device-101-what-counts-what-doesnt-and-why-it-matters/2025-10-08T10:48:46+00:00https://regulatorypathfinder.com/fda-vs-mdr-two-very-different-worlds-of-medical-device-regulation/2025-10-08T10:33:39+00:00https://regulatorypathfinder.com/post-4-figuring-out-your-devices-risk-class-and-why-its-step-1/2025-10-08T10:26:49+00:00https://regulatorypathfinder.com/post-5-what-your-risk-class-means-in-practice-docs-costs-and-clinical-trials/2025-10-08T10:22:03+00:00https://regulatorypathfinder.com/digital-health-master-class-lesson-6/2025-10-08T10:11:03+00:00https://regulatorypathfinder.com/us-healthcare-system/2025-10-08T09:35:48+00:00https://regulatorypathfinder.com/risk-class-i-samd/2025-10-06T12:13:04+00:00https://regulatorypathfinder.com/fda-to-weigh-in-on-ai-mental-health-tools/2025-09-29T18:58:09+00:00https://regulatorypathfinder.com/cer/2025-10-06T12:09:20+00:00https://regulatorypathfinder.com/uhc-store/2025-10-22T07:02:16+00:00https://regulatorypathfinder.com/supplement-revision-or-new-device/2026-02-16T15:16:46+00:00